boARD & LEADERSHIP

Dr. Shane is the Chief Executive Officer and has served as Chairman of the Board since the company’s inception. Up until 2009 Dr. Shane also served as President and CEO of Tiger Management International, a private management company that deals in business management of private and public companies. Dr. Shane resigned all positions and closed Tiger Management International in 2009. Dr. Shane was founder and CEO of Integrated Healthcare Alliance, Inc. and also founder and General Partner of Doctors Hospital West Covina, California. Prior thereto, Dr. Shane practiced podiatric surgery specializing in ankle arthroscopy.

Ms. Elissa J. Shane is the Chief Operating Officer and serves as Director since August 2, 2021. She began her career with the company in August of 2015 in the role of Chief Regulatory and Compliance Officer. Soon thereafter she became Secretary of the Company from January 2016 to December 2017, while also serving as the Operations and Compliance Officer from December 2016 – December 2017. Prior to that, Ms. Shane was a paralegal with Levi Lubarsky Feigenbaum & Weiss LLP, where she worked with the firm's partners and staff attorneys to manage all operational aspects of the litigation cycle, from inception through appeal. Additionally, she worked as a paralegal with the partners at The Lustigman Firm PC before joining them when they merged with Olshan Frome Wolosky LLP. In these roles, Ms. Shane managed regulatory and compliance issues, litigation procedures and advertising and promotional matters. Her extensive legal career also includes several years at the internationally recognized leading law firm of Fried Frank Harris Shriver & Jacobson and also the intellectual property specialist firm of Kenyon & Kenyon LLP.

Mr. Vanston is an experienced financial executive with over 25 years of international finance and operational leadership across the life sciences, manufacturing, and technology sectors. From November 2024 to February 2025, he served as Chief Financial Officer of Jon-Don LLC, a portfolio company of Incline Partners. From October 2023 to November 2024, he was Vice President of Finance at Flexan LLC, a medical device manufacturer and subsidiary of ILC Dover, then a portfolio company of New Mountain Capital. From April 2021 to October 2023, Mr. Vanston served as Chief Financial Officer of Arcmed, a contract manufacturer in the life sciences sector and a portfolio company of Halma plc. Prior to that, from April 2017 to February 2021, he was Chief Financial Officer of VolitionRx, a multinational epigenetics company listed on the NYSE focused on developing blood-based diagnostics for cancer and other NETosis-related diseases. Mr. Vanston holds an MBA from Warwick University and is a Fellow of the Chartered Certified Accountants in the United Kingdom.

The Company appointed Mr. Francesco Fragasso as a Director on September 11, 2025. Mr. Fragasso served as the Chief Financial Officer of Hamilton Thorne Ltd., a publicly traded company listed on the Toronto Stock Exchange (TSX: HTL), since August 2022 to January 2025. From 2018 to 2022, he served as Chief Financial Officer of Fluence Corporation Ltd. (ASX: FLC), a global water infrastructure company listed on the Australian Securities Exchange. Mr. Fragasso served as Vice President and Chief Financial Officer at Desalitech, Inc. from 2015 to 2018, and served as Corporate CFO and Vice President of Operations at Novara Fuel Cells, Inc. (Hess Corp. Group NYSE: HESS) from 2001 to 2014. He previously held senior finance and operations roles at MMN SpA and Deloitte SpA in Italy. Mr. Fragasso is a European Chartered Public Accountant and holds an MBA from Boston University and a Bachelor and Master of Science in Business and Economics from Università Bocconi in Milan, Italy.

The Company appointed Mr. Harold W. Paul as a Director on September 25, 2025. Mr. Paul has been engaged in the private practice of law for more than 40 years, primarily as a securities specialist, during which time he has served as outside legal counsel to public companies listed on national securities exchanges. Mr. Paul has also served as a director for six public companies in a variety of industries, including technology and financial services. He holds a Bachelor of Arts from the State University of New York at Stony Brook and a Juris Doctor from Brooklyn Law School, and is admitted to practice law in New York and Connecticut.

Dr. Lim brings over 25 years of working experience in the banking and finance industry to the TOMI™ board. He is a fellow of the Singapore Institute of Directors and is currently an Independent Non-Executive Director on the board of two publicly-listed companies on the Singapore Stock Exchange. Dr. Lim has worked in various senior management positions for several regional and multi-national organizations, including UBS Capital Asia Pacific Limited, The NatSteel Group, Rothschild Ventures Asia Limited and The Singapore Technologies Group.